Sequential treatment with AT-101 enhances cisplatin chemosensitivity in human non-small cell lung cancer cells through inhibition of apurinic/apyrimidinic endonuclease 1-activated IL-6/STAT3 signaling pathway
2016 ◽
Vol 49
(4)
◽
pp. 1360-1368
◽
Keyword(s):
Keyword(s):